Subscribe free

HPB & Spleen ·

No Long-Term Outcome Difference in Gallbladder Cancer Resection

Surgeons can expect similar long-term outcomes when choosing between segment 4b/5 and wedge resection for gallbladder adenocarcinoma.

  • 163 patients underwent randomized surgeries; segment 4b/5 took longer (318 min vs. 287 min) and had higher blood loss (265 ml vs. 223 ml).
  • No differences in morbidity, mortality, or R0 resection rates were observed.
  • At 27 months follow-up, mean disease-free survival was 41.8 months (4b/5) vs. 44.7 months (wedge), and mean overall survival was 45.3 months (4b/5) vs. 50.7 months (wedge).

Surgeons can select either technique without impacting oncological outcomes.

Clinical Trial, Phase III by Singh S, Aggarwal A (…) Talwar V et 2 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →